Brief: Polypid Announces 500Th Patient Enrolled In Shield I Phase 3 Clinical Trial Of D-Plex₁₀₀ In Abdominal Surgery
18/11/2021 12:32
Nov 18 (Reuters) - PolyPid Ltd PYPD.O :
* POLYPID ANNOUNCES 500TH PATIENT ENROLLED IN SHIELD I PHASE
3
CLINICAL TRIAL OF D-PLEX₁₀₀ IN ABDOMINAL SURGERY
Source text for Eikon: ID:nGNX7cNyyN
Further company coverage: PYPD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Polypid
See all newsPolyPid Ltd reports results for the quarter ended June 30 - Earnings Summary
PolyPid Ltd expected to post a loss of 38 cents a share - Earnings Preview
Brief: Polypid Announces FDA Acceptance Of NDA With Priority Review For D-Plex₁₀₀
PolyPid, Azurity sign surgical site infection drug deal
Brief: Polypid Initiates D-Plex₁₀₀ NDA Submission To The FDA